Aolanti Weikang Tablets
- Generic Name
- Aolanti Weikang Tablets
Study of Aolanti Weikang Tablets in Healthy Volunteers
Phase 1
Completed
- Conditions
- Functional Dyspepsia
- Interventions
- Other: Placebo
- First Posted Date
- 2017-11-30
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT03358485
- Locations
- 🇨🇳
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath